U.S. Luxury Stock News

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

CTO Realty Growth ( NYSE:CTO ) Second Quarter 2025 Results Key Financial Results Revenue: US$37.6m (up 31% from 2Q...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

Cboe Global Markets has announced it will wind down its Japanese equities business, including ceasing operations for its proprietary trading system and block trading platform, with plans to suspend activities by August 29, 2025, pending regulatory consultations. This move reflects Cboe's approach to concentrate its efforts and resources on markets and opportunities deemed more likely to enhance shareholder value amidst changing business conditions in Japan. We'll explore how Cboe's exit from...

Werner Enterprises ( NASDAQ:WERN ) Second Quarter 2025 Results Key Financial Results Revenue: US$753.1m (down 1.0% from...

The Creative Global Technology Holdings Limited ( NASDAQ:CGTL ) share price has softened a substantial 32% over the...

Key Insights Golden Matrix Group's significant insider ownership suggests inherent interests in company's expansion 61...

In July 2025, the US District Court for the District of Massachusetts dismissed Roku's effort to have a global FRAND royalty rate set for the HEVC Advance Patent Pool, determining it lacked jurisdiction over an international patent portfolio spanning 117 countries. This outcome underscores the territorial nature of patent law and emphasizes that US courts do not serve as venues for setting worldwide licensing terms, spotlighting the importance of jurisdiction in complex global patent...

Finward Bancorp ( NASDAQ:FNWD ) Second Quarter 2025 Results Key Financial Results Revenue: US$16.9m (up 16% from 2Q...

With its stock down 11% over the past week, it is easy to disregard GreenTree Hospitality Group (NYSE:GHG). It is...

On July 28, 2025, Ascendis Pharma announced that the U.S. FDA approved SKYTROFA (lonapegsomatropin-tcgd), extending its use from pediatric to adult patients with growth hormone deficiency based on positive Phase 3 clinical trial results. This milestone expands SKYTROFA’s addressable patient population, reflecting both clinical progress and potential for increased commercial opportunities in the adult segment. We’ll examine how FDA approval of SKYTROFA for adult use could shape Ascendis...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Ternium S.A. recently reported its second quarter and first half 2025 earnings, showing net income of US$215 million for the quarter and US$282 million for the half-year, both reversing net losses in the same periods last year despite lower sales. A key insight is that the company achieved basic earnings per share gains even as revenues declined, signaling a significant operational turnaround and improved profitability. We'll explore how Ternium's return to profitability despite revenue...

In late July 2025, fuboTV announced a new multi-year partnership with Weigel Broadcasting to add seven entertainment and sports networks, while also providing improved earnings guidance for the second quarter, projecting a net loss of approximately US$8 million, an improvement of around US$18 million year-over-year. This expanded content deal enhances fuboTV’s offerings in key markets and the updated financial outlook reflects operational progress in narrowing losses. We'll now examine how...

Chefs' Warehouse recently reported second quarter 2025 results, showing sales of US$1.03 billion and net income of US$21.24 million, both higher than the previous year, along with raised full-year guidance for net sales and gross profit. A two-stage discounted cash flow analysis estimates the company’s shares may be substantially undervalued, highlighting the importance of assessing future cash flows and underlying business fundamentals. With new guidance projecting higher sales and profit,...

Reynolds Consumer Products recently reported second quarter earnings, revealing US$938 million in sales with net income of US$73 million, and reiterated expectations for low single digit declines in revenues for both the third quarter and full year 2025. The announcement highlights ongoing operational and demand pressures, as flat revenues alongside reduced profitability may raise questions about near-term growth resilience. We'll explore how the company's forecast for ongoing revenue...

Guardant Health reported strong second quarter results with sales rising to US$232.09 million and narrowed its net loss, while also raising its full-year 2025 revenue outlook and announcing positive clinical results from the RADIOHEAD study. The publication from the RADIOHEAD trial highlights Guardant Reveal's ability to predict immunotherapy response months earlier than traditional methods, potentially improving treatment decisions for advanced-stage cancer patients. We'll examine how the...

Bitmine Immersion Technologies announced a share repurchase program of up to US$1 billion, following recent capital-raising actions including a private placement totaling US$182 million and a shelf registration filing for US$1.80 billion. This sequence of financial moves underscores the company’s intent to balance capital structure flexibility with shareholder-focused initiatives. Next, we'll explore how management’s decision to authorize a major buyback shapes the current investment...

Neurocrine Biosciences recently reported its second quarter 2025 earnings, posting US$687.5 million in revenue and US$107.5 million in net income, both higher than the same period last year, and announced the termination of a Phase 2 trial for NBI-921352 due to insufficient efficacy. Despite this clinical development setback, the company’s lead pipeline programs remain on track and earnings momentum has drawn continued positive attention from industry analysts. We'll explore how strong...

Global Industrial Company recently reported its second quarter 2025 financial results, posting sales of US$358.9 million and net income of US$25.1 million, both higher than the same period last year. The company’s basic and diluted earnings per share rose to US$0.65 from US$0.52 a year ago, reflecting improved profitability and operational performance. We'll explore how this earnings outperformance impacts the company’s investment narrative, particularly its drive for higher margins and...

On July 28, 2025, the lock-up agreements restricting Amer Sports’ directors, officers, and key shareholders from transferring certain shares expired after a 60-day period tied to the company’s latest prospectus, opening up the potential for insider share sales. This development comes amid heightened capital market activity for Amer Sports, with several recent secondary offerings and increased analyst coverage placing greater attention on the company’s near-term share supply and corporate...

Pomerantz LLP announced that a class action lawsuit was filed in the United States District Court for the District of Connecticut against Biohaven Ltd. and certain officers, alleging violations of federal securities laws between March 24, 2023 and May 14, 2025. This legal action brings renewed scrutiny to Biohaven’s leadership and disclosure practices, raising questions about potential impacts on stakeholder confidence. We’ll examine how these legal challenges could influence Biohaven’s...

Western Digital recently reported earnings for the year ended June 27, 2025, posting US$9.52 billion in sales and a net income of US$1.89 billion, a turnaround from a net loss the previous year. The company's return to profitability, along with guidance for continued revenue growth in the next quarter, highlights renewed confidence in business momentum. We'll examine how Western Digital's shift to annual profitability and new quarterly guidance could impact its investment narrative and...

Raymond James Financial reported its third quarter and nine-month earnings for the period ended June 30, 2025, showing higher nine-month revenue and net income, alongside updates on its ongoing share repurchase program. The company emphasized its milestone of 150 consecutive profitable quarters, an expanded legal reserve, and highlighted top rankings for client and adviser satisfaction. Now, we'll examine how Raymond James' accelerated share buyback efforts factor into its evolving...